RadNet, Inc. is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company has a network of around 293 owned and/or operated outpatient imaging centers, including around 74 facilities in the greater New York Metropolitan area. Its core markets include California, Maryland, Delaware, New Jersey, New York and Rhode Island. The Company's centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company's services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company has around 213 MRI systems, 125 CT systems, 44 PET or combination PET/CT systems, 274 X-ray systems, 392 ultrasound systems, 44 nuclear medicine systems, 226 mammography systems and 168 fluoroscopy systems in operation.